Advertisement
Short communication|Articles in Press

Intraoperative rupture and chemotherapy use in stage I ovarian cancer

  • Koji Matsuo
    Correspondence
    Corresponding author at: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, 2020 Zonal Avenue, IRD 520, Los Angeles, CA 90033, USA.
    Affiliations
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA

    Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • Alesandra R. Rau
    Affiliations
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • Hiroko Machida
    Affiliations
    Department of Obstetrics and Gynecology, University of Tokai School of Medicine, Kanagawa, Japan
    Search for articles by this author
  • Lynda D. Roman
    Affiliations
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA

    Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • Jason D. Wright
    Affiliations
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Search for articles by this author
Published:March 17, 2023DOI:https://doi.org/10.1016/j.ejogrb.2023.03.015
Intraoperative rupture and chemotherapy use in stage I ovarian cancer
Previous ArticleNon-Excisional Therapeutic Modalities In Vaginal Intraepithelial Neoplasia
Next ArticleWITHDRAWN: Recruitment of pregnant women to randomised trials of COVID 19 treatments, and pharmaceutical treatments received outside such trials: A research article
      Ovarian capsule rupture during surgery for stage IA-B ovarian cancer changes the cancer stage to IC1 disease. Not only does this upstage the tumor, but intraoperative capsule rupture is associated with decreased survival [
      • Matsuo K.
      • Huang Y.
      • Matsuzaki S.
      • Klar M.
      • Roman L.D.
      • Sood A.K.
      • et al.
      Minimally invasive surgery and risk of capsule rupture for women with early-stage ovarian cancer.
      JAMA Oncol. 2020; 6: 1110
      ,
      • Matsuo K.
      • Machida H.
      • Yamagami W.
      • Ebina Y.
      • Kobayashi Y.
      • Tabata T.
      • et al.
      Intraoperative capsule rupture, postoperative chemotherapy, and survival of women with stage i epithelial ovarian cancer.
      Obstet Gynecol. 2019; 134: 1017-1026
      ,
      • Dioun S.
      • Wu j.
      • Chen l.
      • Kaplan s.
      • Huang y.
      • Melamed a.
      • et al.
      Intraoperative rupture of the ovarian capsule in early-stage ovarian cancer: a meta-analysis.
      Obstet Gynecol. 2021; 138: 261-271
      ]. As such, intraoperative rupture may influence the decision to offer postoperative chemotherapy [

      Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf (accessed 10/10/2022).

      ]. A prior investigation suggested that adjuvant chemotherapy may not improve survival in case of capsule rupture [
      • Matsuo K.
      • Machida H.
      • Yamagami W.
      • Ebina Y.
      • Kobayashi Y.
      • Tabata T.
      • et al.
      Intraoperative capsule rupture, postoperative chemotherapy, and survival of women with stage i epithelial ovarian cancer.
      Obstet Gynecol. 2019; 134: 1017-1026
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Obstetrics and Gynecology and Reproductive Biology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Matsuo K.
        • Huang Y.
        • Matsuzaki S.
        • Klar M.
        • Roman L.D.
        • Sood A.K.
        • et al.
        Minimally invasive surgery and risk of capsule rupture for women with early-stage ovarian cancer.
        JAMA Oncol. 2020; 6: 1110
        View in Article
        • Matsuo K.
        • Machida H.
        • Yamagami W.
        • Ebina Y.
        • Kobayashi Y.
        • Tabata T.
        • et al.
        Intraoperative capsule rupture, postoperative chemotherapy, and survival of women with stage i epithelial ovarian cancer.
        Obstet Gynecol. 2019; 134: 1017-1026
        View in Article
        • Dioun S.
        • Wu j.
        • Chen l.
        • Kaplan s.
        • Huang y.
        • Melamed a.
        • et al.
        Intraoperative rupture of the ovarian capsule in early-stage ovarian cancer: a meta-analysis.
        Obstet Gynecol. 2021; 138: 261-271
        View in Article

      4. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf (accessed 10/10/2022).

        View in Article

      5. Surveillance, Epidemiology, and End Results Program, National Cancer Institute. https://seer.cancer.gov/ (accessed 12/06/2022).

        View in Article

      Article info

      Publication history

      Published online: March 17, 2023
      Accepted: March 16, 2023
      Received in revised form: February 21, 2023
      Received: December 6, 2022

      Publication stage

      In Press Journal Pre-Proof

      Identification

      DOI: https://doi.org/10.1016/j.ejogrb.2023.03.015

      Copyright

      © 2023 Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX